On May 29, 2025, Enveric Biosciences, Inc. held its 2025 Annual Meeting where 1,206,498 shares (48.81% of the total) were represented. Key votes included approving six directors, an advisory say-on-pay resolution, and conditional approval for a potential reverse stock split.